JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB247055

Anti-OAT3 antibody

4

(1 Review)

|

(2 Publications)

Rabbit Polyclonal OAT3 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human SLC22A8 aa 250-350.

View Alternative Names

OAT3, SLC22A8, Organic anion transporter 3, hOAT3, Organic anion/dicarboxylate exchanger, Solute carrier family 22 member 8

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-OAT3 antibody (AB247055)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-OAT3 antibody (AB247055)

Paraffin-embedded human kidney tissue stained for OAT3 using ab247055 at 1/2500 dilution in immunohistochemical analysis.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-OAT3 antibody (AB247055)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-OAT3 antibody (AB247055)

Paraffin-embedded human lymph node tissue stained for OAT3 using ab247055 at 1/2500 dilution in immunohistochemical analysis. Low expression as expected.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Recombinant Fragment Protein within Human SLC22A8 aa 250-350. The exact immunogen used to generate this antibody is proprietary information.

Q8TCC7

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/2500 - 1/5000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol." } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein OAT3 also known as organic anion transporter 3 and encoded by the SLC22A8 gene plays a critical role in the transport of endogenous and exogenous organic anions. This protein has a molecular mass of approximately 60 kDa. OAT3 is primarily expressed in the basolateral membrane of kidney proximal tubule cells where it facilitates the exchange of organic anions with dicarboxylates. It contributes to the renal uptake of various substances including drugs and waste products from the blood.
Biological function summary

OAT3 serves an important role in the detoxification processes by mediating the clearance of xenobiotics and metabolites. It is not part of a larger complex but works in concert with other renal transporters to maintain homeostasis. OAT3 efficiently transports several drugs such as members of the cephalosporin family and antiviral agents and endogenous compounds like prostaglandins and cyclic nucleotides. These functions highlight its necessity in pharmacokinetics and renal drug elimination.

Pathways

OAT3 significantly impacts the renal organic anion transport pathway and the cellular response to organic substances. It participates alongside other transporters like OAT1 and OATP1B1 to manage the flow of metabolic byproducts and ensure efficient drug clearance. These interactions form an essential component of the detoxification pathway and drug disposition which are vital for maintaining organismal health.

OAT3 relates significantly to conditions such as chronic kidney disease and drug-induced nephrotoxicity. Impairments in OAT3 function can lead to altered drug excretion and accumulation of toxic substances worsening renal pathology. Additionally reduced OAT3 activity has links with urate transporter proteins like URAT1 affecting uric acid clearance and contributing to gout. Understanding OAT3 interactions and regulation helps in identifying therapeutic strategies for these conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Functions as an organic anion/dicarboxylate exchanger that couples organic anion uptake indirectly to the sodium gradient (PubMed : 14586168, PubMed : 15644426, PubMed : 15846473, PubMed : 16455804, PubMed : 31553721). Transports organic anions such as estrone 3-sulfate (E1S) and urate in exchange for dicarboxylates such as glutarate or ketoglutarate (2-oxoglutarate) (PubMed : 14586168, PubMed : 15846473, PubMed : 15864504, PubMed : 22108572, PubMed : 23832370). Plays an important role in the excretion of endogenous and exogenous organic anions, especially from the kidney and the brain (PubMed : 11306713, PubMed : 14586168, PubMed : 15846473). E1S transport is pH- and chloride-dependent and may also involve E1S/cGMP exchange (PubMed : 26377792). Responsible for the transport of prostaglandin E2 (PGE2) and prostaglandin F2(alpha) (PGF2(alpha)) in the basolateral side of the renal tubule (PubMed : 11907186). Involved in the transport of neuroactive tryptophan metabolites kynurenate and xanthurenate (PubMed : 22108572, PubMed : 23832370). Functions as a biopterin transporters involved in the uptake and the secretion of coenzymes tetrahydrobiopterin (BH4), dihydrobiopterin (BH2) and sepiapterin to urine, thereby determining baseline levels of blood biopterins (PubMed : 28534121). May be involved in the basolateral transport of steviol, a metabolite of the popular sugar substitute stevioside (PubMed : 15644426). May participate in the detoxification/ renal excretion of drugs and xenobiotics, such as the histamine H(2)-receptor antagonists fexofenadine and cimetidine, the antibiotic benzylpenicillin (PCG), the anionic herbicide 2,4-dichloro-phenoxyacetate (2,4-D), the diagnostic agent p-aminohippurate (PAH), the antiviral acyclovir (ACV), and the mycotoxin ochratoxin (OTA), by transporting these exogenous organic anions across the cell membrane in exchange for dicarboxylates such as 2-oxoglutarate (PubMed : 11669456, PubMed : 15846473, PubMed : 16455804). Contributes to the renal uptake of potent uremic toxins (indoxyl sulfate (IS), indole acetate (IA), hippurate/N-benzoylglycine (HA) and 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF)), pravastatin, PCG, E1S and dehydroepiandrosterone sulfate (DHEAS), and is partly involved in the renal uptake of temocaprilat (an angiotensin-converting enzyme (ACE) inhibitor) (PubMed : 14675047). May contribute to the release of cortisol in the adrenals (PubMed : 15864504). Involved in one of the detoxification systems on the choroid plexus (CP), removes substrates such as E1S or taurocholate (TC), PCG, 2,4-D and PAH, from the cerebrospinal fluid (CSF) to the blood for eventual excretion in urine and bile (By similarity). Also contributes to the uptake of several other organic compounds such as the prostanoids prostaglandin E(2) and prostaglandin F(2-alpha), L-carnitine, and the therapeutic drugs allopurinol, 6-mercaptopurine (6-MP) and 5-fluorouracil (5-FU) (By similarity). Mediates the transport of PAH, PCG, and the statins pravastatin and pitavastatin, from the cerebrum into the blood circulation across the blood-brain barrier (BBB). In summary, plays a role in the efflux of drugs and xenobiotics, helping reduce their undesired toxicological effects on the body (By similarity).
See full target information SLC22A8

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Communications biology 7:177 PubMed38418614

2024

Modular tissue-in-a-CUBE platform to model blood-brain barrier (BBB) and brain interaction.

Applications

Unspecified application

Species

Unspecified reactive species

Isabel Koh,Masaya Hagiwara

Cell proliferation 55:e13190 PubMed35102634

2022

Functional differentiation and scalable production of renal proximal tubular epithelial cells from human pluripotent stem cells in a dynamic culture system.

Applications

Unspecified application

Species

Unspecified reactive species

Thao Thi Thanh Ngo,Bella Rossbach,Isabelle Sébastien,Julia C Neubauer,Andreas Kurtz,Krithika Hariharan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com